|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 14 of 17 found articles
| Title: |
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial |
| Author: |
Hungria, Vania Hus, Marek Fu, ChengCheng Zherebtsova, Vera Ward, Christopher Ho, P Joy Mikulski, Damian Muronova, Ludmila Cerchione, Claudio Loubert, Angely Bunod, Laurine M'Hari, Manal Pirooz, Nick Rogers, Rachel Lin, Chee Paul Roy-Ghanta, Sumita Opalinska, Joanna B Purser, Molly McKeown, Astrid McNamara, Simon Baig, Hena Eccersley, Lydia Pompilus, Farrah Mateos, María-Victoria |
| Appeared in: |
The Lancet. Haematology |
| Paging: | Volume 12 () nr. 8 pages e599-e610 |
| Year: |
2025 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 14 of 17 found articles
| << previous | next >> |